Table 1.
Biomarker | Injury | Source | Test | Unit | Healthy controls (range) |
Cystatin C | Proximal tubule injury | Serum | Nephelometric immunoassay/ELISA | mg/L | 0.53-0.95[38] |
0. 85 ± 0.21[39] | |||||
Urine | Nephelometric immunoassay/ELISA | mg/L | 0.051-0.28[37] | ||
0.02-0.11[96] | |||||
NGAL | Ischemia and nephrotoxins | Serum | ELISA | ng/mL | 86.3 ± 43.0 (men)[54] |
88.9 ± 38.2 (women)[54] | |||||
56.71 ± 17.57[39] | |||||
1.7 ± 0.5[55] | |||||
0.4-100[56] | |||||
Urine | ELISA | ng/mL | 5.7-17.7[55] | ||
11.94 ± 8.09[39] | |||||
0.8-28.9 (men)[96] | |||||
1.9-316.7 (women)[96] | |||||
KIM-1 | Ischemia and nephrotoxins | Urine | ELISA | pg/mL | 59-2146[70] |
395.1 ± 398.8[39] | |||||
31.0-1000.0[56] | |||||
31.0-1736.5[96] | |||||
IL-18 | Toxic, delayed graft function | Urine | ELISA | pg/mL | 1.4-1.8[80] |
3.0-108.6[96] | |||||
6.2-311.1[96] | |||||
L-FABP | Ischemia and nephrotoxins | Urine | ELISA | ng/mL | 3-400[83] |
μg/gCr | 5.67 (2.74-8.21)[87] | ||||
NAG | Tubule injury | Urine | Colorimetry | U/g | 0.75-0.90 U/g[95] |
1.06 ± 0.1 U/g (children)[90] |
Lower reference values are not presented due to the detection limit of 0.05 mg/L. NGAL: Neutrophil gelatinase-associated lipocalin; KIM-1: Kidney injury molecule-1; IL-18: Interleukin-18; L-FABP: Liver-type fatty acid binding protein; NAG: N-acetyl-β-D-glucosaminidase; ELISA: Enzyme-linked immunosorbent assay; U: Unit.